Harold Schaaff
@Soleus Capital Management, L.p.
Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.
Assets under management
The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BLCOBausch Plus Lomb Corp
| 0.47% | $6.018M 312,000 shares@ $19.29 avg price | New Position |
ARVNArvinas Inc
| 0.44% | $5.635M 228,800 shares@ $24.63 avg price | New Position |
SLNSilence Therapeutics Plc
| 0.37% | $4.727M 260,000 shares@ $18.18 avg price | New Position |
ABBVAbbvie Inc
| 0.25% | $3.11M 15,750 shares@ $197.48 avg price | New Position |
MDXHMdxhealth Sa
| 0.18% | $2.298M 1.105M shares@ $2.08 avg price | New Position |
VCYTVeracyte Inc
| 0.15% | $1.848M 54,303 shares@ $34.04 avg price | New Position |
ABVXAbivax Sa
| 0.12% | $1.44M 125,000 shares@ $11.52 avg price | New Position |